Discontinued — last reported Q4 '19
AT&T Other Intangible Assets, Net decreased by 0.0% to $5.25B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.0%, from $5.26B to $5.25B. Over 4 years (FY 2020 to FY 2024), Other Intangible Assets, Net shows a downward trend with a -23.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A high value indicates a strong portfolio of intellectual property, while a declining value may signal the approaching expiration of key patents.
This includes identifiable non-physical assets such as patents, trademarks, licenses, and acquired drug rights, net of a...
Crucial for comparing the strength of drug pipelines and competitive advantages among pharmaceutical peers.
other_intangibles_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.74B | $12.34B | $11.78B | $11.45B | $5.37B | $5.36B | $5.35B | $5.35B | $5.34B | $5.33B | $5.28B | $5.28B | $5.28B | $5.26B | $5.26B | $5.26B | $5.26B | $5.25B |
| QoQ Change | — | -3.1% | -4.5% | -2.8% | -53.1% | -0.2% | -0.1% | -0.1% | -0.1% | -0.1% | -0.9% | -0.0% | -0.1% | -0.4% | -0.0% | +0.0% | +0.0% | -0.0% |
| YoY Change | — | — | — | — | -57.8% | -56.5% | -54.6% | -53.3% | -0.6% | -0.6% | -1.3% | -1.2% | -1.2% | -1.4% | -0.5% | -0.5% | -0.4% | -0.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.